Journal of Applied Physiology AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


J Appl Physiol (September 15, 2005). doi:10.1152/japplphysiol.00306.2005
This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
100/2/707    most recent
00306.2005v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sommer, S. L
Right arrow Articles by Kumar, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sommer, S. L
Right arrow Articles by Kumar, R.
Submitted on March 16, 2005
Accepted on September 9, 2005

Elevated Blood Pressure and Cardiac Hypertrophy Following Ablation of the gly96/IEX-1 Gene

Stacy L Sommer1, Theresa J Berndt2, Elena Frank1, Jeetendra B Patel1, Margaret M Redfield1, Xiangyang Dong1, Matthew D Griffin1, Joseph P Grande3, Jan M. A. van Deursen4, Gary C Sieck5, Juan C Romero2, and Rajiv Kumar6*

1 Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
2 Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
3 Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
4 Pediatrics and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, Minnesota, Algeria
5 Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
6 Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA; Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, Minnesota, Algeria

* To whom correspondence should be addressed. E-mail: rkumar{at}mayo.edu.

IEX 1/gly96 is a growth and apoptosis-regulating, immediate early gene that is widely expressed in epithelial and vascular tissues. In vascular tissues, expression of the gene is induced by mechanical stretch, and over-expression of the gene prevents injury-induced vascular smooth muscle hypertrophy and neointimal hyperplasia. We now show that deletion of the gly96/IEX-1 gene in mice is associated with development of elevated blood pressure, cardiac hypertrophy and diminished fractional shortening of the left ventricle. Systolic blood pressure in conscious male gly96/IEX-1-/- mice is 20-25 mm Hg higher than in gly96/IEX-1+/+ mice. Serum and/or urine concentrations of sodium, potassium, creatinine, angiotensin II, corticosterone, aldosterone, epinephrine, nor-epinephrine, prostaglandin E2, thromboxane B2, prostaglandin 6 keto 1{alpha}, nitrites and nitrates, cyclic AMP and cyclic GMP are normal in gly96/IEX-1-/- mice. Alterations in dietary sodium intake do not alter blood pressure in gly96/IEX-1-/- mice. Aortic messenger RNAs for endothelial nitric oxide synthase, guanylate cyclase {alpha} and cyclic GMP kinase 1 are increased in gly96/IEX-1-/- mice. Treatment with L-NAME or L-arginine does not alter blood pressure in gly96/IEX-1-/- mice. Gly96/IEX-1-/- mice respond to infused sodium nitroprusside with decrements in blood pressure similar to those seen in wild type littermate mice. In contrast to gly96/IEX-1 transgenic mice that have abnormalities in immune function, gly96/IEX-1-/- mice have normal lymphoid tissue architecture and a normal complement of T- and B-cells in lymphoid tissues. Ablation of the gly96/IEX-1 gene results in hypertension and cardiac hypertrophy suggesting a novel role for this gene in cardiovascular physiology.




This article has been cited by other articles:


Home page
Cancer Res.Home page
D. P. Steensma, J. D. Neiger, J. C. Porcher, J. J. Keats, P. L. Bergsagel, T. R. Dennis, R. A. Knudson, R. B. Jenkins, R. Santana-Davila, R. Kumar, et al.
Rearrangements and Amplification of IER3 (IEX-1) Represent a Novel and Recurrent Molecular Abnormality in Myelodysplastic Syndromes
Cancer Res., October 1, 2009; 69(19): 7518 - 7523.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. S. Lai, J. S. Parker, S. F. Grissom, D. J. Stumpo, and P. J. Blackshear
Novel mRNA Targets for Tristetraprolin (TTP) Identified by Global Analysis of Stabilized Transcripts in TTP-Deficient Fibroblasts
Mol. Cell. Biol., December 15, 2006; 26(24): 9196 - 9208.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1948 by the American Physiological Society.